Mangosteen Garcinia mangostana L.
Also called: purple mangosteen, mangosteen pericarp, mangosteen peel
Mangosteen is a tropical fruit tree native to Peninsular Malaysia and Borneo. The fruit is eaten as food; dietary supplements and most clinical studies use the pericarp (fruit hull), while mangosteen juice products are marketed separately as health drinks.
- Category
- Botanical
- Part used
- Pericarp (fruit hull) extracts in supplements and trials; juice products are a different preparation
- Strongest evidence
- B Some positive trials
- Native range
- Native to Peninsular Malaysia and Borneo (POWO: "Pen. Malaysia, Borneo")
- Reviewed
- 2026-10-30
Class 2 Moderately studied in people. Four RCTs of oral mangosteen extract alone (three pericarp, one fruit-pulp extract) were found: schizophrenia (148 people, 2021), bipolar depression (152, 2025), Alzheimer's disease (108, 2022) and insulin resistance (22 women, 2018). No source stating a total trial count was found. [2]
Fact-checked 2026-10-30 · How this guide is made
Education, not medical advice. These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure or prevent any disease, or to replace any medication or medical advice. EUTECNIQ sells no supplements today, and this page links to no product. Supplements can interact with medicines; ask a doctor or pharmacist before use, especially in pregnancy, while breastfeeding, before surgery or for a child.
What research has studied
Grades describe the human evidence in the cited sources, not a recommendation. A means consistent randomized trials; X means good trials found no effect.
BMouth and teeth1 topic
CBlood sugar and weight1 topic
A consistent trialsB some positive trialsC limited human evidenceD lab or animal onlyX no effect in good trials
| Topic studied | Grade | What the evidence shows |
|---|---|---|
| Bipolar depression (pericarp extract added to usual care) | C | A 24-week RCT (152 adults randomized) found overall depressive-symptom change did not substantially differ from placebo; some mood, severity and functioning measures improved at week 24, and these differences faded after stopping. [2] |
| Schizophrenia or schizoaffective disorder (pericarp added to usual care) | C | A 24-week double-blind RCT (148 people, 1,000 mg/day pericarp) found no between-group difference from placebo in the rate of symptom change; the authors concluded the results do not support it. [3] |
| Cognition in mild to moderate Alzheimer's disease | C | A 24-week RCT (108 participants) of a water-soluble pericarp extract found more participants in the low-dose group than on placebo reached a clinically important ADAS-Cog improvement, with a trend at the high dose. [4] |
| Insulin resistance in women with obesity | C | A 26-week randomized pilot (22 women, 20 completed) comparing behavioral therapy with or without mangosteen extract reported a significant improvement in insulin sensitivity in the mangosteen group. [5] |
| Periodontitis (pericarp gel applied in the gum pocket) | B | A 2025 meta-analysis of RCTs found mangosteen local delivery gel reduced pocket depth (effect size -1.08) and clinical attachment level (-0.96) in RCTs comparing it with placebo or conventional therapies. [6] |
| Exercise fatigue (single dose of a mangosteen-based juice) | C | A crossover RCT in 12 healthy adults found a single 250 mL dose of mangosteen-based juice taken before cycling did not alleviate physical fatigue versus placebo, apart from a mood-questionnaire difference. [7] |
Main constituents: Xanthones, including alpha-, beta- and gamma-mangostin, garcinone B and E, gartanin and isogarcinol; studied mainly in laboratory settings [1]
Amounts studied and limits
Amounts used in research, not dosing advice. Products differ in form and strength; a clinician can advise on an individual dose.
- Pericarp 1,000 mg/day for 24 weeks (schizophrenia trial). [3]
- Water-soluble pericarp extract 4 mg/kg/day for 24 weeks, or 4 mg/kg/day for 12 weeks then 8 mg/kg/day for 12 weeks (Alzheimer's disease trial). [4]
- 4% mangosteen gel used as an adjunct to scaling and root planing (periodontitis studies). [8]
No official upper intake level has been set.
Safety and side effects
- Liver (NIH LiverTox)Nothing found
No published information found in the sources checked.
Details and sources - Pregnancy and breastfeedingNothing found
No published information found in the sources checked.
Details and sources - Interactions with medicines3 listed
Chemotherapy and radiation therapy; Calcineurin inhibitors (cyclosporine, tacrolimus); Cytochrome P450 substrates
Details and sources - Cancer evaluations (IARC, NTP)None found
No IARC or NTP evaluation was found in the lists checked.
Details and sources - FDA new dietary ingredient notifications2 on FDA's list
FDA does not approve dietary supplements. Each entry is one party's filing.
Details and sources - Dose in official monographsNone found
No published information found in the sources checked.
Details and sources
- Case report: severe lactic acidosis after drinking mangosteen juice daily for 12 months. [1]
- MSK lists diabetes among reasons not to use mangosteen products, stating that mangosteen is high in sugar. [1]
- In mice, alpha-mangostin worsened experimental colitis; clinical relevance is unknown. [1]
- In the 24-week Alzheimer's disease trial, the water-soluble pericarp extract appeared safe and well tolerated. [4]
Interactions
| With | What happens |
|---|---|
| Chemotherapy and radiation therapy | MSK: antioxidant effects may interfere with anthracyclines, platinum compounds and alkylating agents. [1] |
| Calcineurin inhibitors (cyclosporine, tacrolimus) | MSK: possible additive immunosuppression; clinical relevance is unknown. [1] |
| Cytochrome P450 substrates | MSK: mangosteen inhibits CYP1A1, CYP1A2, CYP2E1 and CYP3A11 (the study MSK cites was in mice); clinical significance is not known. [1] |
Tell a pharmacist or doctor about every supplement you take. All documented interactions in this hub.
Identity, quality and standardization
Regulatory status
- US: under DSHEA, FDA does not have the authority to approve dietary supplements before they are marketed; firms are responsible for ensuring their products are not adulterated or misbranded. [10]
Safety, quality and supply profile
Fourteen questions a careful buyer, formulator or clinician would ask, each answered only from a cited source (checked 2026-10-29). If our sources do not answer a question, we say so.
Compounds responsible
Compounds the sources name as the main or characteristic actives.
- Xanthones of the fruit, including alpha-, beta- and gamma-mangostin, garcinone B and E, gartanin and isogarcinol (studied mainly in laboratory settings) Xanthones (PubChem describes alpha-mangostin as a member of the class of xanthones) [P1]
US status
What FDA's published records show. FDA does not approve dietary supplements.
- FDA's published NDI notification list has 2 entries naming mangosteen (earliest NDI 862 submitted 2015-02-12, a multi-ingredient combination listing "Mangostana garicinia"; most recent NDI 1409 submitted 2025-06-02, "Mangosteen Peel Extract"). Each notification covers one firm's specific ingredient and conditions of use; the list does not state FDA's response. [P3]
Cancer evaluations (IARC and NTP)
Evaluations name the exact material tested, which may differ from a supplement.
- No IARC or NTP carcinogenicity evaluation of mangosteen (Garcinia mangostana) or alpha-mangostin was found (IARC Monographs list of classifications, Volumes 1–142, and NTP technical reports checked 2026-10-29). [P4]
- The NTP Technical Reports index (TR-001 to TR-606) lists no study of mangosteen or Garcinia (checked 2026-10-29). [P5]
Liver (NIH LiverTox)
- No published information found in the sources checked.
Interactions with medicines
- Chemotherapy and radiation therapy: MSK: antioxidant effects may interfere with anthracyclines, platinum compounds and alkylating agents. [P1]
- Calcineurin inhibitors (cyclosporine, tacrolimus): MSK: possible additive immunosuppression; clinical relevance is unknown. [P1]
- Cytochrome P450 substrates: MSK: mangosteen inhibits CYP1A1, CYP1A2, CYP2E1 and CYP3A11 (the study MSK cites was in mice); clinical significance is not known. [P1]
Alcohol
- No published information found in the sources checked.
Interactions with other herbs and supplements
- No published information found in the sources checked.
Adulteration and substitution
- No published information found in the sources checked.
What a certificate of analysis should cover
Tests a quality specification for this material would include, with the reason for each.
- Identity: at least one appropriate test or examination to verify the identity of each component that is a dietary ingredient (21 CFR 111.75(a)(1)(i)) — General Part 111 requirement for every dietary ingredient; a firm may petition FDA for an exemption under 111.75(a)(1)(ii). [P6]
Supply and conservation
- IUCN Red List: Data Deficient (DD), via GBIF species API, retrieved 2026-10-29. [P7]
Absorption in people
- In a randomized placebo-controlled study in 20 healthy adults, after a single 245 mL dose of a beverage containing mangosteen with aloe vera, green tea and multivitamins, alpha-mangostin was detected in plasma by LC/MS with Cmax at around 1 h (multi-ingredient product). [P8]
Formulations studied to change absorption
Human data only.
- No published information found in the sources checked.
Dose in official monographs
As the monograph states it, for its jurisdiction; not personal advice.
- No published information found in the sources checked.
Pregnancy and breastfeeding
- No published information found in the sources checked.
Sources for this profile
- Memorial Sloan Kettering Cancer Center. About Herbs: Mangosteen (Last Updated February 22, 2023), 2023-02-22. mskcc.org
- PubChem. Alpha-mangostin, CID 5281650: description (retrieved 2026-10-29), 2026-10-29. pubchem.ncbi.nlm.nih.gov
- FDA. Submitted 75-Day Premarket Notifications for New Dietary Ingredients (list dated July 9, 2026), 2026-07-09. fda.gov
- IARC Monographs. List of Classifications, Volumes 1–142 (retrieved 2026-10-29), 2026-10-29. monographs.iarc.who.int
- National Toxicology Program. Technical Reports (TR series index, TR-001 to TR-606; retrieved 2026-10-29), 2026-10-29. ntp.niehs.nih.gov
- eCFR. 21 CFR 111.75, What must you do to determine whether specifications are met? (up to date as of 10/23/2026), 2026-10-23. ecfr.gov
- GBIF species API: IUCN Red List category for Garcinia mangostana L., 2026-10-29. api.gbif.org
- Xie Z, et al. Functional beverage of Garcinia mangostana (mangosteen) enhances plasma antioxidant capacity in healthy adults. Food Sci Nutr 2015;3(1):32-38 (PMID 25649891), 2015-01. pubmed.ncbi.nlm.nih.gov
Sources
- Memorial Sloan Kettering Cancer Center. About Herbs: Mangosteen (Last Updated February 22, 2023), 2023-02-22. mskcc.org
- Dean OM, et al. The efficacy of adjunctive Garcinia mangostana Linn. (mangosteen) pericarp extract for bipolar depression: 24-week randomised controlled trial. Br J Psychiatry 2025;227(6):854-863 (PMID 40637133), 2025-12. pubmed.ncbi.nlm.nih.gov
- Turner A, et al. Adjunctive Garcinia mangostana Linn. (mangosteen) pericarp for schizophrenia: a 24-week double-blind, randomized, placebo controlled efficacy trial. Can J Psychiatry 2021;66(4):354-366 (PMID 33355478), 2021-04. pubmed.ncbi.nlm.nih.gov
- Muangpaisan W, et al. Effects of water-soluble mangosteen extract on cognitive function and neuropsychiatric symptoms in patients with mild to moderate Alzheimer's disease (WECAN-AD): a randomized controlled trial. Alzheimers Dement (N Y) 2022;8(1):e12292 (PMID 35415207), 2022-04. pubmed.ncbi.nlm.nih.gov
- Watanabe M, et al. Mangosteen extract shows a potent insulin sensitizing effect in obese female patients: a prospective randomized controlled pilot study. Nutrients 2018;10(5):586 (PMID 29747432), 2018-05. pubmed.ncbi.nlm.nih.gov
- Ramesh KSV, et al. Efficacy of mangosteen as local drug delivery for improving periodontal health in adults with periodontitis: a systematic review and meta-analysis of randomized controlled trials. J Complement Integr Med 2025;22(4):563-573 (PMID 40314616), 2025-05. pubmed.ncbi.nlm.nih.gov
- Chang CW, et al. Acute Garcinia mangostana (mangosteen) supplementation does not alleviate physical fatigue during exercise: a randomized, double-blind, placebo-controlled, crossover trial. J Int Soc Sports Nutr 2016;13:20 (PMID 27152103), 2016-05. pubmed.ncbi.nlm.nih.gov
- Estornut C, et al. Impact of antioxidant mangosteen on clinical and biochemical parameters of periodontitis: a systematic review. Planta Med 2026;92(7):717-729 (PMID 41461206), 2026-06. pubmed.ncbi.nlm.nih.gov
- Purwoko Y, et al. Effects of Garcinia mangostana peel extract on glycemic control in type 2 diabetes mellitus: a systematic review of human studies. Acta Med Indones 2026;58(1):52-58 (PMID 41978307), 2026-01. pubmed.ncbi.nlm.nih.gov
- U.S. Food and Drug Administration. Questions and Answers on Dietary Supplements (Content current as of 08/27/2026), 2026-08-27. fda.gov
- Plants of the World Online (POWO), Royal Botanic Gardens, Kew; WCVP data. Garcinia mangostana L. (accessed 2026-10-29; native range: "Pen. Malaysia, Borneo"), 2026-10-29. powo.science.kew.org
- A
- Consistent results from several randomized trials or a systematic review of them
- B
- Some positive randomized trials, but small, short, few or inconsistent
- C
- Limited human evidence: single small trials, observational data or mixed results
- D
- Laboratory or animal evidence only; not shown in people
- X
- Well-designed human trials found no meaningful effect
More in botanical: Aloe vera · American ginseng · Amla · Andrographis · Arjuna · Arnica · Aronia (black chokeberry) · Asafoetida · All entries A–Z · How to judge a supplement
Health information notice
These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease. The information is for general education only. It is not medical advice and does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed.
Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.
EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.